{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:19:52Z","timestamp":1783059592160,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA269231"],"award-info":[{"award-number":["R01CA269231"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mri.2026.110706","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:31:50Z","timestamp":1779899510000},"page":"110706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of diffusion-weighted MRI in assessing Ewing sarcoma treatment response: Findings from a COG phase III trial"],"prefix":"10.1016","volume":"132","author":[{"given":"Ricarda","family":"von Kr\u00fcchten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"DelRocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bhushan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Shokri","family":"Varniab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Glade","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Krailo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike E.","family":"Daldrup-Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2026.110706_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.mri.2026.110706_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.2017.74.7402","article-title":"Rhabdomyosarcoma, Ewing sarcoma, and other round cell sarcomas","volume":"36","author":"Pappo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mri.2026.110706_bb0015","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","article-title":"Ewing sarcoma: current management and future approaches through collaboration","volume":"33","author":"Gaspar","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mri.2026.110706_bb0020","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.22.01815","article-title":"Randomized phase III trial of ganitumab with interval-compressed chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"41","author":"DuBois","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mri.2026.110706_bb0025","doi-asserted-by":"crossref","first-page":"77050","DOI":"10.18632\/oncotarget.20335","article-title":"Initial FDG-PET\/CT predicts survival in adults with Ewing sarcoma family of tumors","volume":"8","author":"Jamet","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mri.2026.110706_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00259-016-3509-z","article-title":"The role of FDG PET\/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas","volume":"44","author":"Palmerini","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mri.2026.110706_bb0035","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/MPH.0000000000001518","article-title":"Clinical and prognostic role of 18F-FDG PET\/CT in pediatric Ewing sarcoma","volume":"42","author":"Albano","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.mri.2026.110706_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13244-022-01177-9","article-title":"Multiparametric MRI evaluation of bone sarcomas in children","volume":"13","author":"Inarejos Clemente","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.mri.2026.110706_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2015.01.022","article-title":"Prognostic factors and patterns of relapse in Ewing sarcoma patients treated with chemotherapy and R0 resection","volume":"92","author":"Pan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.mri.2026.110706_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RLI.0b013e31819dcc84","article-title":"Diffusion-weighted imaging as a predictor of therapy response in an animal model of Ewing sarcoma","volume":"44","author":"Reichardt","year":"2009","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0055","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200257","article-title":"Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing\u2019s sarcoma","volume":"93","author":"Saleh","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0060","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00256-021-03741-8","article-title":"Diffusion-weighted imaging for the differentiation of Ewing sarcoma from osteosarcoma","volume":"50","author":"Parlak","year":"2021","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00280","article-title":"Utility of multiparametric quantitative magnetic resonance imaging for characterization and radiotherapy response assessment in soft-tissue sarcomas and correlation with histopathology","volume":"9","author":"Winfield","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.mri.2026.110706_bb0070","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mri.2026.110706_bb0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2214\/AJR.13.11304","article-title":"Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET\/MRI","volume":"201","author":"Rakheja","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.mri.2026.110706_bb0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.mri.2026.110706_bb0085","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"10.1016\/j.mri.2026.110706_bb0090","first-page":"869","article-title":"When SUV matters: FDG PET\/CT at baseline correlates with survival in soft tissue and Ewing sarcoma","volume":"11","author":"Hack","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.mri.2026.110706_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108855","article-title":"The value of diffusion-weighted imaging and apparent diffusion coefficient in primary osteogenic and Ewing sarcomas for the monitoring of response to treatment: initial experience","volume":"124","author":"Asmar","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00256-009-0830-7","article-title":"The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient","volume":"39","author":"Oka","year":"2010","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0105","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00330-006-0342-y","article-title":"Monitoring therapeutic responses of primary bone tumors by diffusion-weighted imaging: initial results","volume":"16","author":"Hayashida","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0110","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00247-021-05037-4","article-title":"Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update","volume":"51","author":"Habre","year":"2021","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/01.rli.0000225398.17315.68","article-title":"Osteosarcoma","volume":"41","author":"Uhl","year":"2006","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0120","article-title":"Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.mri.2026.110706_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinimag.2017.08.003","article-title":"Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors","volume":"47","author":"Degnan","year":"2018","journal-title":"Clin Imaging"},{"key":"10.1016\/j.mri.2026.110706_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1302\/0301-620X.81B2.0810317","article-title":"Tumor volume as a predictor of necrosis after chemotherapy in Ewing\u2019s sarcoma","volume":"81","author":"Abudu","year":"1999","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.mri.2026.110706_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1148\/radiol.2016151301","article-title":"Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome","volume":"280","author":"Aghighi","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2026.110706_bb0140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2967\/jnumed.112.115964","article-title":"Combination of 18F-FDG PET\/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma","volume":"54","author":"Byun","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.mri.2026.110706_bb0145","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.7150\/jca.20077","article-title":"18F-FDG PET\/CT as an indicator of survival in Ewing sarcoma of bone","volume":"8","author":"Salem","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.mri.2026.110706_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109076","article-title":"Post-treatment FDG PET\/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET","volume":"129","author":"Sobic Saranovic","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.mri.2026.110706_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153281","article-title":"Prognostic value of SUVmax measured by pretreatment fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with Ewing sarcoma","volume":"11","author":"Hwang","year":"2016","journal-title":"PloS One"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X26000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X26000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:32:01Z","timestamp":1783056721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X26000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0730725X26000998"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2026.110706","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of diffusion-weighted MRI in assessing Ewing sarcoma treatment response: Findings from a COG phase III trial","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2026.110706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110706"}}